Home / Inspections / 1218973

FDA Inspection 1218973 — Orion Corporation, Orion Pharma

Orion Corporation, Orion Pharma — FEI 3003073605

The FDA completed an inspection of Orion Corporation, Orion Pharma on June 2, 2022 in Espoo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 2, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Espoo (Finland)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1310408 (VAI Thu Nov 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1156118 (VAI Thu Sep 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1053840 (VAI Fri Jun 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1012832 (VAI Fri Apr 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987011 (VAI Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources